SARS-CoV-2 Spike humanized Antibody, clone 2A1
MerckSARS-CoV-2 Nucleocapsid, clone 2A1 Monoclonal Antibody (matched pair with clone 2C1)
SARS-CoV-2 Nucleocapsid, clone 2A1 Monoclonal Antibody (matched pair with clone 2C1)
SARS-CoV-2 Nucleocapsid, clone 2C1 Monoclonal Antibody (matched pair with clone 2A1)
SARS-CoV-2 Nucleocapsid, clone 4D8 Monoclonal Antibody (matched pair with clone 5B7)
SARS-CoV-2 Nucleocapsid, clone 5B7 Monoclonal Antibody (matched pair with clone 4D8)
SARS-CoV-2 Nucleocapsid,clone 7B3 Monoclonal Antibody (matched pair with clone 5D4)
SARS-CoV-2 Nucleoprotein (aa 1-419) Recombinant Antigen, 613
SARS-CoV-2 Spike (RBD, aa 331-524) Recombinant Antigen
SARS-CoV-2 Spike Protein S1 (aa 1-674) Recombinant Antigen
Fetal Bovine Serum (FBS) is the most widely-used growth supplement for cell culture, containing a complex mixture of biomolecules that includes growth factors, proteins, trace elements, vitamins and hormones for cell growth. Our extensive portfolio of FBS enables you to easily select the right FBS for your culture and criteria.
Highly characterized, cryopreserved human colon intestinal organoids derived from integration-free human induced pluripotent stem cells (iPSCs).
The 3dGRO™ Human Lung Organoid Culture System is a multi-stage culture system for efficient differentiation of human induced pluripotent stem (iPS) cells to mature lung organoids.
Decellularized extracellular matrix (dECM) hydrogels for 2D and 3D cell culture applications.
Ready-to-use, 96-well black-walled glass-bottom microplates containing precast synthetic hydrogels designed to easily establish 3D cell cultures by direct seeding of cells.
Validated, ethically-sourced human primary and stem cells from industry-leading manufacturer PromoCell ® .
Primer and probe pools for the U.S. CDC and and Charité tests.
Sigma-Aldrich ® one-part sgRNA and two-part crRNA:tracrRNA systems accelerate genome editing with Cas9 protein, mRNA, or established Cas9 expressing cell lines. Our guides are compatible with a variety of delivery methods including microinjection, electroporation, and lipofection.
With the largest portfolio of Cas9 proteins available, Merck make it easy to find the perfect nuclease for your gene editing experiment.
Merck's immuno-oncology cell lines are innovative research tools for biologics discovery and clinical development. These are the perfect cell-based assay tools you need for the entire drug discovery and clinical development process. Whether you need screening tools for CAR/TCR therapies and mAB development, target cells for efficacy testing, or potency assays for clinical development, Merck provides functional biologically-re…
The largest and most validated shRNA collection from the RNAi consortium (TRC). Merck's unique shRNA formats leverage the discovery potential of the trusted and proven TRC shRNA collection. When you partner with them, you gain access to their world class lentiviral production expertise and the formats and specifications for RNAi knockdown experiments at any scale.
A comprehensive biobank of highly characterized tissue-derived human gastrointestinal organoids from normal and diseased patients.
Nuclease-independent applications of CRISPR provide equal targeting specificity but instead of cutting, CRISPRi allows for targeted interference of gene function by delivering transcriptional repressor domains to a specific target sequence using modified dCas9 + gRNA complexes. Gene knockdown is complementary to CRISPR-KO and CRISPRa (activation) and has distinct advantages over existing loss-of-function strategies like RNAi.…
Patient-derived organoids (PDOs) are novel in vitro 3D cell models that preserve original tissue physiology and molecular pathology.